EPISODE · Dec 30, 2025 · 6 MIN
FDA Approves Oral Wegovy: Novo Nordisk Launches Groundbreaking Weight Loss Pill Offering New Hope for Obesity Management
from Wegovy · host Inception Point AI
# Wegovy Pill: FDA Approves First Oral GLP-1 Therapy for Weight Management - Global Health Watch Podcast Discover the groundbreaking FDA approval of Novo Nordisk's Wegovy pill, the first oral GLP-1 treatment for chronic weight management. Host Alexandra Reeves explores how this once-daily pill matches the impressive 16.6% weight loss results of injectable Wegovy without needles or refrigeration. Learn about the OASIS 4 trial results, pricing strategies, competitive landscape with Eli Lilly, and California Medi-Cal coverage changes. This episode unpacks how this convenient oral semaglutide option could revolutionize obesity treatment for millions who avoided injections, with insights on effectiveness, side effects, and real-world impact for those managing obesity and related health conditions. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
Embed this episode
NOW PLAYING
FDA Approves Oral Wegovy: Novo Nordisk Launches Groundbreaking Weight Loss Pill Offering New Hope for Obesity Management
No transcript for this episode yet
Similar Episodes
No similar episodes found.